Selected Grants
The Gut Brain Parkinson's Disease Consortium (GBPDC): Coordinating and Data Management Center (CDMC)
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2024 - 2029Duke University Program in Environmental Health
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2019 - 2029Automated High-purity Exosome isolation-based AD diagnostics system (AHEADx)
ResearchCo-Principal Investigator · Awarded by National Institute on Aging · 2023 - 2028Which mechanisms of pollutant-induced mitochondrial dysfunction cause dopaminergic neurodegeneration?
ResearchCo Investigator · Awarded by National Institutes of Health · 2023 - 2027Medical Scientist Training Program
Inst. Training Prgm or CMEPreceptor · Awarded by National Institute of General Medical Sciences · 2022 - 2027CIRCUIT MECHANISMS FOR DOPAMINE NEURON VULNERABILITY AND RESILIENCE IN PD - Extension
ResearchCollaborator · Awarded by Michael J. Fox Foundation for Parkinson's Research · 2021 - 2026LRRK2-HDAC6 pathway as a mediator of tau neurotoxicity in Parkinson's disease (Buck, Silas)
ResearchPrincipal Investigator · Awarded by Parkinson Foundation · 2024 - 2026Mechanisms of mitochondrial genome integrity in familial and idiopathic Parkinson's disease
ResearchPrincipal Investigator · Awarded by National Institute of Neurological Disorders and Stroke · 2020 - 2025Identifying kinase signaling pathways linked to tau-mediated neurodegeneration
ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2023 - 2025Alzheimer's Association Communication
ResearchPrincipal Investigator · Awarded by Alzheimer's Association · 2024 - 2025Regulation of LRRK2 in lysosomal stress response
ResearchCo Investigator · Awarded by National Institute of Neurological Disorders and Stroke · 2023 - 2025Optimization of methods to process samples for detection of mtDNA damage
ResearchPrincipal Investigator · Awarded by Neuron23 · 2024 - 2024mtDNA sample analysis
ResearchPrincipal Investigator · Awarded by NRG Therapeutics Ltd · 2024 - 2024Phase 1b Parkinson's Disease
ResearchPrincipal Investigator · Awarded by Allyx Therapeutics, Inc · 2023 - 2024An acoustofluidic device for diagnosing preclinical Alzheimer's disease
ResearchCo Investigator · Awarded by Ascent Bio-Nano Technologies, Inc. · 2022 - 2024AB22002 - A dose-ranging study to investigate efficacy and safety of buntanetap in participants with early AD
Clinical TrialPrincipal Investigator · Awarded by Annovis Bio, Inc. · 2022 - 2024SBT-272 - collaboration with Stealth Bio
ResearchPrincipal Investigator · Awarded by Michael J. Fox Foundation for Parkinson's Research · 2023 - 2024DNA Blood Sampling Services - Option Year 1
ResearchPrincipal Investigator · Awarded by San Francisco VA Health Care System · 2021 - 2023CSF EV Mito DNA workflow: Determination of feasibility of measurement of Mitochondrial DNA and Mitochondrial DNA integrity in human CSF-derived extracellular vesicles (EV)
ResearchPrincipal Investigator · Awarded by Escape Bio · 2022 - 2022Interactions between the immune system, genetics and environmental mitochondrial toxicants in models of Parkinson's disease
ResearchPrincipal Investigator · Awarded by Department of Defense · 2020 - 2022DNA Blood Sampling Services - Base Year
ResearchPrincipal Investigator · Awarded by San Francisco VA Health Care System · 2021 - 2022Profiling postoperative neuroinflammation in a mouse model of delirium superimposed on Parkinson's disease.
ResearchCo-Mentor · Awarded by Harvard University · 2020 - 2021Supplement: Mitochondrial DNA damage as a blood-based biomarker of early Parkinson's disease
ResearchPrincipal Investigator · Awarded by Michael J. Fox Foundation for Parkinson's Research · 2020 - 2021Cross-validation of LRRK2 biomarkers
ResearchPrincipal Investigator · Awarded by Michael J. Fox Foundation for Parkinson's Research · 2019 - 2021Mechanisms of pathogenesis in LRRK2-related Parkinson's disease
FellowshipPrincipal Investigator · Awarded by William N. & Bernice E. Bumpus Foundation · 2018 - 2021Mitochondrial DNA damage in PD and control in a pesticide-exposed cohort
ResearchPrincipal Investigator · Awarded by University of California - San Francisco · 2018 - 2021Mitochondrial DNA damage: screening tool and novel therapeutic target for Parkinson's disease
ResearchPrincipal Investigator · Awarded by William N. & Bernice E. Bumpus Foundation · 2017 - 2019Mitochondrial DNA damage as a blood-based biomarker of early Parkinson's disease
ResearchPrincipal Investigator · Awarded by Michael J. Fox Foundation for Parkinson's Research · 2017 - 2019Mitochondrial DNA damage in brain and blood in Alzheimer's disease
ResearchPrincipal Investigator · Awarded by University of Pittsburgh · 2017 - 2019The Anti-Aging Role of Klotho in Skeletal Muscle Regeneration
ResearchPrincipal Investigator · Awarded by University of Pittsburgh · 2017 - 2019LRRK2 kinase activity and mitochondrial DNA damage in Parkinson's disease
ResearchPrincipal Investigator · Awarded by Michael J. Fox Foundation for Parkinson's Research · 2017 - 2018External Relationships
- Honoria from speaking engagements
- Lucy Therapeutics
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.